These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6371145)

  • 1. A rapid technique for measuring leukocyte chemotaxis in vivo.
    Lawman MJ; Boyle MD; Gee AP; Young M
    J Immunol Methods; 1984 Apr; 69(2):197-206. PubMed ID: 6371145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of human neutrophil chemotaxis by the protein kinase inhibitor, 1-(5-isoquinolinesulfonyl) piperazine.
    Harvath L; McCall CE; Bass DA; McPhail LC
    J Immunol; 1987 Nov; 139(9):3055-61. PubMed ID: 2822802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deactivation of human neutrophil chemotaxis by chemoattractants: effect on receptors for the chemotactic factor f-Met-Leu-Phe.
    Donabedian H; Gallin JI
    J Immunol; 1981 Sep; 127(3):839-44. PubMed ID: 6790618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil-endothelial cell interactions. Modulation of neutrophil adhesiveness induced by complement fragments C5a and C5a des arg and formyl-methionyl-leucyl-phenylalanine in vitro.
    Tonnesen MG; Smedly LA; Henson PM
    J Clin Invest; 1984 Nov; 74(5):1581-92. PubMed ID: 6501563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urokinase: a chemotactic factor for polymorphonuclear leukocytes in vivo.
    Boyle MD; Chiodo VA; Lawman MJ; Gee AP; Young M
    J Immunol; 1987 Jul; 139(1):169-74. PubMed ID: 2953811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered polymorphonuclear leukocyte responses in psoriasis: chemotaxis and degranulation.
    Preissner WC; Schröder JM; Christophers E
    Br J Dermatol; 1983 Jul; 109(1):1-8. PubMed ID: 6860565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired motility of neonatal PMN leukocytes: relationship to abnormalities of cell orientation and assembly of microtubules in chemotactic gradients.
    Anderson DC; Hughes BJ; Wible LJ; Perry GJ; Smith CW; Brinkley BR
    J Leukoc Biol; 1984 Jul; 36(1):1-15. PubMed ID: 6376671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of density changes and chemotactic receptors of leukocytes from chronic hemodialysis and peritoneal dialysis patients.
    Lewis SL; Van Epps DE; Chenoweth DE
    Blood Purif; 1987; 5(2-3):138-54. PubMed ID: 3040039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipopolysaccharide modulates receptors for leukotriene B4, C5a, and formyl-methionyl-leucyl-phenylalanine on rabbit polymorphonuclear leukocytes.
    Goldman DW; Enkel H; Gifford LA; Chenoweth DE; Rosenbaum JT
    J Immunol; 1986 Sep; 137(6):1971-6. PubMed ID: 3018083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demonstration of receptor-mediated chemotaxis by human spermatozoa. A novel quantitative bioassay.
    Gnessi L; Ruff MR; Fraioli F; Pert CB
    Exp Cell Res; 1985 Nov; 161(1):219-30. PubMed ID: 4054232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective inhibition of human neutrophil chemotaxis to N-formyl-methionyl-leucyl-phenylalanine by sulfones.
    Harvath L; Yancey KB; Katz SI
    J Immunol; 1986 Aug; 137(4):1305-11. PubMed ID: 3016092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diverging effects of chemotactic serum peptides and synthetic f-Met-Leu-Phe on neutrophil locomotion and adhesion.
    Keller HU; Wissler JH; Damerau B
    Immunology; 1981 Mar; 42(3):379-83. PubMed ID: 7203527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of neutrophil migratory function in burn injury by complement activation products.
    Solomkin JS; Nelson RD; Chenoweth DE; Solem LD; Simmons RL
    Ann Surg; 1984 Dec; 200(6):742-6. PubMed ID: 6508405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidized N-formylmethionyl-leucyl-phenylalanine: effect on the activation of human monocyte and neutrophil chemotaxis and superoxide production.
    Harvath L; Aksamit RR
    J Immunol; 1984 Sep; 133(3):1471-6. PubMed ID: 6086757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct demonstration of increased intracellular concentration of free calcium in rabbit and human neutrophils following stimulation by chemotactic factor.
    White JR; Naccache PH; Molski TF; Borgeat P; Sha'afi RI
    Biochem Biophys Res Commun; 1983 May; 113(1):44-50. PubMed ID: 6305358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement activation in cystic fibrosis respiratory fluids: in vivo and in vitro generation of C5a and chemotactic activity.
    Fick RB; Robbins RA; Squier SU; Schoderbek WE; Russ WD
    Pediatr Res; 1986 Dec; 20(12):1258-68. PubMed ID: 3540828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ionic basis of chemotaxis. Separate cation requirements for neutrophil orientation and locomotion in a gradient of chemotactic peptide.
    Marasco WA; Becker EL; Oliver JM
    Am J Pathol; 1980 Mar; 98(3):749-68. PubMed ID: 6767408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific receptor sites for chemotactic peptides on human polymorphonuclear leukocytes.
    Williams LT; Snyderman R; Pike MC; Lefkowitz RJ
    Proc Natl Acad Sci U S A; 1977 Mar; 74(3):1204-8. PubMed ID: 265563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Independent regulation of human neutrophil chemotactic receptors after activation.
    Bender JG; Van Epps DE; Chenoweth DE
    J Immunol; 1987 Nov; 139(9):3028-33. PubMed ID: 2822801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoattractants induce rapid release of the interleukin 1 type II decoy receptor in human polymorphonuclear cells.
    Colotta F; Orlando S; Fadlon EJ; Sozzani S; Matteucci C; Mantovani A
    J Exp Med; 1995 Jun; 181(6):2181-6. PubMed ID: 7760005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.